The syndrome of bacterial overgrowth in children with chronic gastritis
Journal Title: Актуальна інфектологія - Year 2017, Vol 5, Issue 2
Abstract
Background. Achlorhydria of any origin may be one of the main causes of bacterial overgrowth syndrome (BOS). The data on this controversial issue, some researchers argue the association of long-term use of proton pump inhibitors (PPI) with BOS development. The purpose was to study the clinical manifestations and the state of microbiota of the upper intestine in children with chronic gastritis and reduced gastric function. Materials and methods. The study involved 65 children with chronic gastritis (CG), aged 7–18 years. The study methods included esophasogastroduodenoscopy, biopsy of the gastric mucosa for H. pylori, pH-meter; ultrasound investigation of the abdominal cavity. Mucosa morphological changes were assessed by visual analogue scale. A hydrogen breath test (HBT) using the analyzer Gastrolyzer load lactulose was performed in all patients in order to verify BOS. The results were presented by the number of observations mean values and their standard deviation and error (M ± m for p < 0.05), relative frequency (%). Results. Of the 65 examined children suffering from CG, 27 persons had hypoacidy hastritis, the average pH was 4.7 ± 0.4. Seventeen children with CG had gastroesophageal reflux (GER). In both groups of patients symptoms of diarrhea and flatulence dominated, but in patients with GER receiving PPIs prevalence and severity of symptoms deteriorated with increasing duration of therapy. The study found that H. pylori infection was registered in 42 (64.6 %) of all children with CG. The HBT results demonstrated that more than a third (44.4 %) patients had BOS. In children with CG combined with GER positive HBT was registered in 41.1 % cases. The BOS incidence in these patients was found to enhance with increasing duration of PPI intake. Conclusions. A high incidence of complaints related to the BOS development was found in children with hypoacid CG and in patients with GER treated with PPIs. BOS in patients with CG and patients who have been treated with PPIs, was verified by HBT (44.4 % and 41.1 %, respectively).
Authors and Affiliations
T. V. Sorokman, L. V. Shvugar, P. M. Moldovan,
Keywords
Related Articles
- EP ID EP213226
- DOI 10.22141/2312-413x.5.2.2017.105322
- Views 91
- Downloads 0
Abstracts of the research-to-practice conference with international participation “Actual infectious diseases. Modern aspects of the clinical picture, diagnosis, treatment and prevention” dedicated to the memory of M.M. Horodetskyi
.
Mortality from influenza among the Ukrainian population in 2015–2016 epidemic season
Influenza and acute respiratory viral infections (ARVI) are one of the most urgent medical and socio-economic problems of the country. This is due to the high prevalence of these disease, their complexity, high mortality...
The Current Situation on Malaria in Astrakhan Region
The purpose of the study. To describe the current situation on malaria in Astrakhan region for 2000–2014. Materials and methods. The first data on malarious situation in the Astrakhan region belongs to 1894, when in the...
Nature of the Defeat of the Digestive System in Patients with Drug-Resistant Tuberculosis Using 2nd Line Drugs
The prevalence and nature of the defeat of the digestive system, depending on the profile of resistance to antituberculosis drugs in patients with drug-resistant pulmonary tuberculosis in the Chernivtsi region, were esta...
Diagnostic value of modern biomarkers for the development of purulent-bacterial diseases in children
Background. Sepsis is a general clinical problem with high mortality rate and significant material expenses for the treatment. In this regard, biomarkers are being searched for early diagnosis. Materials and methods. 11...